Practice Resource Library

Latest Medical Position Statement

Crohn's Disease Clinical Practice Guideline

This document presents the official recommendations of the AGA Institute on the use of thiopurines, methotrexate and anti–tumor necrosis factor (TNF)-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. 

Read Practice Guideline

Five Things Doctors and Patients Should Question

AGA, in coordination with the ABIM Foundation, Consumer Reports and eight leading medical societies, is pleased to participate in the launch of Choosing Wisely®, a campaign to identify the overuse or misuse of tests or medical procedures.

Learn More

Recent Additions

Education & Meetings
2015 James W. Freston Conference — A Renaissance in the Understanding and Management of IBS

Education & Meetings
AGA Trainee and Young GI Track at DDW

Education & Meetings
Digestive Disease Week® (DDW)

Latest News

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with IBD

Estimating colorectal cancer risk for first-degree relatives

Duration of thiopurine treatment influences colectomy in ulcerative colitis

Patient reported outcome measures for the assessment of Crohn's disease activity